PALI: Director Donald Allen Receives 1,538,700 RSUs
Rhea-AI Filing Summary
Donald Allen, a director of Palisade Bio, Inc. (PALI), was granted 1,538,700 Restricted Stock Units (RSUs) with a transaction date of 10/06/2025. Each RSU converts into one share of common stock unless the company lacks reserved shares, in which case the RSUs may be settled in cash. The RSUs vest for service in three equal annual installments, to be satisfied on the earlier of the next annual meeting of stockholders or the anniversary of 10/06/2025, subject to continued service. Following the grant, the reporting person beneficially owns 1,538,700 shares (direct).
Positive
- Significant retention incentive: grant of 1,538,700 RSUs vests over three years to support continuity
- Alignment with equity holders: RSUs convert to one share each on vesting, tying compensation to company stock performance
Negative
- Potential dilution: 1,538,700 shares will increase outstanding shares if settled in stock
- Cash settlement risk: RSUs may be settled in cash if plan reserves are insufficient, creating a possible cash obligation
Insights
Large service-based RSU grant aligns director pay with shareholder outcomes but creates dilution and a cash-settlement fallback.
The grant of 1,538,700 RSUs provides a multi-year retention incentive tied to continued service and the next annual meeting or the 10/06/2025 anniversary for vesting. Structure converts to common shares on vesting, aligning the director's payout with equity performance while preserving flexibility if share reserve limits exist.
The fallback to cash settlement if the 2021 Equity Incentive Plan lacks reserved shares introduces a potential near-term cash obligation for the company and reduces long-term share dilution predictability. Monitor the company’s share reserve status and future equity plan amendments over the next 12–36 months for clarity on settlement mechanics.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 1,538,700 | $0.00 | -- |
Footnotes (1)
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date.
